Check out our most popular compounded medications! Get Started
Dashboard
Formulas

Sulfasalazine 50 mg/ml Oral Liquid

FDA-approved generic
Dose form
Oral Liquid
Active ingredients
Sulfasalazine
For prescribers
Prescription details
RxThis formula
Dose formSee below
Quantity____
SigAs directed by prescriber
Refills____
PharmacyBayview Pharmacy, Warwick RI, NCPDP 4106882
Copy prescription detailsOrder form
Controlled substance: e-prescribe (EPCS) from your EHR. Faxed and phoned prescriptions cannot be accepted for this preparation.
Send it from your EHR, or fax to (401) 284-4506. How to e-prescribe this formula
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
To prescribe, you must be a verified prescriber.
To prescribe, you must be in a state where we hold an active out-of-state pharmacy license.
Starting at
Fill my prescription
Fill my prescription
Requires a prescription from your own provider. Bayview is a pharmacy and does not prescribe.
Ships within 1 to 2 business days after pharmacist verification
HSA and FSA eligible
Check if we ship to your state
No prescription yet?

Get a sheet with everything your doctor needs to prescribe this and send it to Bayview.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.

For prescribersSign in for prescription details and order forms.
Compounded preparations are prepared by Bayview pursuant to a prescription for an individual patient. They are not FDA-approved and have not been evaluated by FDA for safety or effectiveness.
Sulfasalazine
Oral Liquid
65d769565ce75609339aa9d8
Service area

Can we ship this formula to your state?

Bayview fills prescriptions for patients in Connecticut, Florida, Maine, Massachusetts, New Hampshire, New Jersey, Pennsylvania and Rhode Island. New York patients are served on a limited basis while nonresident pharmacy registration is pending.

Check your state

Available in

Tap a state to check it.

Our current service area

Currently licensed Limited basis, registration pending Not available for this formula Not currently licensed

Select a state on the map or use the checker.

Prepared to a prescriber's order for one patient. Not FDA-approved.

This formulation

This is a compounded oral liquid containing sulfasalazine, prepared to a prescriber's order for one patient. Compounded preparations are not FDA-approved.

FDA product listings

These listings cover every salt or ester form of each drug in the FDA National Drug Code Directory.

FDA-approved products containing sulfasalazine are listed in tablet form. No finished sulfasalazine product of any kind is listed in liquid form.

Storage category and dating

Liquid bases can be aqueous or nonaqueous, and USP <795> classifies the preparation by its water activity. Aqueous preparations carry shorter default beyond-use dates than nonaqueous ones. The date printed on the label is the one to follow.

Sources

Why prescribers order this

Compounded drugs are not FDA-approved. This means that FDA does not review these drugs to evaluate their safety, effectiveness, or quality before they reach patients.

Sulfasalazine is an anti-inflammatory sulfa drug taken by mouth for ulcerative colitis and arthritis that a pharmacy may compound when a prescriber orders it.

About this ingredient

Sulfasalazine joins a sulfonamide, sulfapyridine, to 5-aminosalicylic acid (5-ASA, mesalamine) through an azo bond. Little is absorbed in the upper gut; bacteria in the lower bowel split the bond, releasing 5-ASA, which acts locally to calm intestinal inflammation, and sulfapyridine, which is absorbed. Manufactured products are Azulfidine tablets and Azulfidine EN-tabs delayed-release tablets, plus generics. Both are indicated for mild to moderate ulcerative colitis, as add-on therapy in severe ulcerative colitis, and to lengthen remission between attacks. EN-tabs are also indicated for rheumatoid arthritis and polyarticular-course juvenile rheumatoid arthritis that responded inadequately to salicylates or other NSAIDs. MedlinePlus notes use for Crohn's disease, which is not an FDA-approved indication. A prescriber might order sulfasalazine compounded in a strength or form that is not manufactured. Compounded preparations are not FDA-approved and require a prescription.

Safety and interactions

Sulfasalazine labels carry no boxed warning, but deaths have been reported from allergic reactions, severe blood disorders (agranulocytosis, aplastic anemia), liver and kidney damage, nerve changes and lung scarring. Serious infections, DRESS and severe skin reactions such as Stevens-Johnson syndrome can occur. Do not take it with a sulfa or salicylate (aspirin) allergy, a bowel or urinary blockage, or porphyria. Use caution with asthma or G6PD deficiency. It can reduce absorption of folic acid and digoxin. Drink plenty of fluids, take it after meals, and expect possible orange-yellow urine or skin; MedlinePlus advises limiting sun exposure. It can lower sperm counts, which reverses after stopping. The label advises use in pregnancy only if clearly needed and notes its effect on folic acid. LactMed calls it low risk in breastfeeding but advises watching the infant for diarrhea. Call your prescriber right away about sore throat, fever, pale skin, unusual bruising, yellow skin or eyes, or a rash.

The mode of action of sulfasalazine or its metabolites 5-ASA and sulfapyridine may relate to anti-inflammatory and immunomodulatory properties seen in animal and in vitro models. Absolute oral bioavailability of parent drug is under 15%; colonic bacteria cleave it to sulfapyridine (bioavailability about 60%) and 5-ASA (about 10% to 30%). Sulfasalazine is over 99.3% albumin bound, sulfapyridine about 70%. Plasma half-life of intravenous sulfasalazine is 7.6 hours; sulfapyridine is acetylated, with a half-life of 10.4 hours in fast and 14.8 hours in slow acetylators. Most 5-ASA stays in the colon and is excreted in feces; absorbed metabolites are excreted in urine. Labeled indications: Azulfidine tablets (NDA007073) for ulcerative colitis; Azulfidine EN-tabs (NDA007073) for ulcerative colitis, rheumatoid arthritis and polyarticular-course juvenile rheumatoid arthritis. MedlinePlus lists Crohn's disease as an off-label use. LiverTox describes a rare, idiosyncratic hypersensitivity liver injury, usually within 2 to 6 weeks of starting. Dosing is per prescriber. The label calls for complete blood counts with differential and liver tests before starting and on a set schedule thereafter, plus urinalysis and renal function checks. Sulfasalazine is not a controlled substance.

Sources

Using and storing

How it is used

Shake the bottle if your label says to. Measure each dose with the oral syringe or dosing cup the pharmacy gave you, never a kitchen spoon. Give the liquid slowly into the mouth. Rinse the syringe with water after each use. Call the pharmacy if you are unsure how to measure.

Storing it

Storage depends on the vehicle. Water-based liquids with a preservative usually carry a USP <795> beyond-use date of up to 35 days; without a preservative they are kept refrigerated for up to 14 days. Oil-based (nonaqueous) oral liquids may carry up to 90 days. Your label states whether to refrigerate and the beyond-use date. Keep out of reach of children and discard after that date.

Sources

Prescribing and ordering FAQs

Formula Information

A small arrow pointing down

Drug Interactions

A small arrow pointing down

How Does it Work

A small arrow pointing down

Frequently Asked Questions

A small arrow pointing down

About this compounded preparation

This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.

A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.

Formulas and/or material listed are not to be interpreted as a promise, guarantee or claim of therapeutic efficacy or safety. The information contained herein is not intended to replace or substitute for conventional medical care, or encourage its abandonment. Every patient is unique, and formulas should be adjusted to meet their individual needs.

No compounded medications are reviewed by the FDA for safety or efficacy.
For prescribers

How to e-prescribe this formula

Controlled substance: e-prescribe only (EPCS). Faxed, phoned, and handwritten prescriptions cannot be filled. Rhode Island law (R.I. Gen. Laws § 21-28-3.18) requires Schedule II to V prescriptions to be transmitted electronically.
1

Find Bayview in your EHR's pharmacy directory

Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.

NCPDP4106882NPI1750455143Address3844 Post Rd, Warwick, RI 02886Phone(401) 284-4505Fax(401) 284-4506
2

Enter the formula as a compound

Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.

Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.

3

Copy the prescription details

RxFormula name
Dose formDose form
Quantity________
SigAs directed by prescriber
Refills____
PharmacyBayview Pharmacy, Warwick RI, NCPDP 4106882
Copy prescription details

Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.

4

Send it

Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.

Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.

Do not use Notes to Pharmacy for the formula. Some EHRs keep that field internal and never transmit it. A prescription that arrives without the formula is delayed while we call your office.

Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.

Sulfasalazine 50 mg/ml Oral Liquid
Oral Liquid
controlled

Take orally

Twice daily